AngioDynamics beats fourth-quarter fiscal 2025 estimates with strong Med Tech growth amid margin declines and a wider fiscal 2026 loss outlook.

BLK beats Q2 earnings estimates and posts record $12.52T AUM, but shares dip 6.4% despite strong revenue growth.

BLK beats Q2 earnings estimates and posts record $12.52T AUM, but shares dip 6.4% despite strong revenue growth.

LW's fourth-quarter earnings and sales beat estimates, with 4% year-over-year revenue growth and volume gains despite pricing headwinds.

FLEX beats Q1 forecasts and lifts FY26 outlook, but shares fall 7.7% despite robust data center and power gains.

FLEX beats Q1 forecasts and lifts FY26 outlook, but shares fall 7.7% despite robust data center and power gains.

FAST's second-quarter 2025 results reflect increased sales and improved gross profit margin, despite macro headwinds.

ORLY beats Q2 EPS estimates, raises the 2025 sales outlook and accelerates share buybacks amid steady store growth.

CCK beats Q2 earnings and revenue estimates, lifts full-year EPS outlook on strong beverage segment growth.

CCK beats Q2 earnings and revenue estimates, lifts full-year EPS outlook on strong beverage segment growth.